Endotoxin and nanobacteria in polycystic kidney disease.
and microbe may have added importance and nuance to fully understand the disease process and potential
Methods. Fluids were probed for endotoxin and nanobactherapies.
teria, a new bacterium, by the differential Limulus Amebocyte
Environmental factors are reported to influence the Lysate assay (dLAL), genus-specific antilipopolysaccharide progression of polycystic kidney disease (PKD), the most (LPS) antibodies, monoclonal antibodies to nanobacteria, and prevalent autosomal dominant disease in humans [2] [3] [4] [5] [6] .
hyperimmune serum to Bartonella henselae (HS-Bh). Selected specimens were also assessed by transmission electron microsIn addition to the inherited mutated PKD allele, autosocopy (TEM) and nanobacterial culture methods.
mal dominant PKD (ADPKD) offspring may themselves cyst fluid and urine [9, 17, 18] . LPS is composed of a uals previously reported for endotoxin content was also analyzed for nanobacterial antigens [17] . lipid A moiety, core polysaccharides, and O-antigens. Antibodies to the core polysaccharides of genus-specific Endotoxin in cyst fluids and urine was assayed by dLAL using the gel clot endpoint as previously described LPS have been used to detect microbes in tissue and fluids and provide insight into pathophysiologic mecha-(Charles River ENDOSAFE, Charleston, SC, USA) [9] . Each specimen was assayed in duplicate with serial dilunisms. In this study of endotoxin in PKD, we used genusspecific LPS antibodies to ascertain the microbial origins tions to assess the concentration. To expose epitopes in a few select experiments, nanobacteria were demineralof endotoxin present in human PKD cyst fluids.
In the course of this work, in PKD serum, cyst fluids, ized by incubation in 100 mmol/L EGTA made in sterile, pyrogen-free water for one hour at 37ЊC. Following deand urine we found evidence of nanobacteria, a recently discovered, novel, calcium apatite-forming bacterium mineralization, both the 15,000 ϫ g pellet and supernate were amenable to dLAL and dot immunoblot assay; that is undetectable by routine microbiological culture methods [19] [20] [21] [22] . Nanobacteria exhibit an array of effects such concentrations of EGTA in the specimen did not interfere with these assays. in animals and in vitro culture that are plausibly related to the known anomalies of PKD. For example, intraveFor the detection of LPS antigens, lyophilized cyst fluids reconstituted in commercial pyrogen-free water to nously injected nanobacteria are renotropic and cause apoptosis of kidney tubule cells and sloughing of renal one tenth of their original volume were dot blotted (2 L) onto nitrocellulose paper, blocked with 3% gelatin, inditubule cells into the urine, and they are found in 97% of kidney stones [23] [24] [25] [26] [27] . Nanobacteria cause mineralizavidually exposed to genus specific anti-LPS antibody prepared in mouse or rabbit, washed, probed with a horsetion in vitro under physiological concentrations of calcium and phosphate [20, 21, 24, 25] . Dysregulation of radish peroxidase (HRP)-linked antimouse or antirabbit IgG secondary antibody, washed, and reacted with HRPapoptosis and tubular obstruction is reported in PKD, as is a heightened occurrence of kidney calcification amplifying reagents to give a purple color [33] . Negative controls included pyrogen-free water as specimen; PKD [28] [29] [30] [31] . Awareness that viable nanobacteria are present and control specimens were processed as experimental, in human PKD kidney is important for future tests of except that incubation with the primary antibody was environmental factors that impact the genetically unique omitted. Positive controls used genus-specific LPS as aspects of PKD biology as well as broader issues of the the test specimens. The intensity of HRP reaction was role of nanobacteria in health and disease.
visually estimated and rated from 0 to 5, the greatest intensity. Monoclonal antibodies (mAbs) against "Nano-METHODS bacterium sanguineum" antigens were used separately Kidneys from 13 patients with ADPKD were obtained as the primary antibody in the dot immunoblot assays in cold University of Wisconsin solution [32] within two described earlier in this article. [Note: "Nanobacterium hours of nephrectomy at UICOM-Department of Sursanguineum" is the type culture designate for nanobacgery, St. Francis Medical Center (Peoria, IL, USA). Hanteria. It has been deposited in the German Collection of dling of the kidneys and aspirated cyst fluids was done Microorganisms (DSMZ no. 5819; Braunschweig, Gerusing aseptic techniques, tools rendered pyrogen-and many) and is described in U.S. patent no. 5,135,851,1992. glucan-free by heating at 160ЊC for four hours, and pyroThe 16S rRNA gene sequence is available in GENBANK gen-and fungal glucan-free reagents, as determined by (accession No. X98418). "N. sanguineum" was isolated differential Limulus Amebocyte Lysate assay (dLAL) from bovine serum and is the source of antigens used in [9] . The dLAL distinguished endotoxin from fungal gluthe preparation of mAbs.] Dot-immunoblot assays used cans. Cyst fluids were individually aspirated, cultured by the following antibodies [34]: Enteric mAb WN1222.5 routine microbiological methods, and stored at Ϫ60ЊC for rough/smooth LPS of Escherichia coli, Salmonella, for later analysis of endotoxin content, immunodetecShigella; Bacteroides "C" (common LPS antigen) polytion, transmission electron microscopy (TEM), and naclonal antiserum; mAb B7 to Chlamydia spp. LPS; mAb nobacteria culture, as described later in this article. In Nb 8/0 (porin protein epitope) and Nb 5/2 (carbohydrate one PKD patient (donor 2; A visual scoring scheme rated the intensity of the immunoreactions from 0 to 5, the highest positivity. Positive reaction scores were averaged. assess any cross-reactivity of primary antibodies between For ADPKD patient 14, cyst fluids were collected as mentioned previously in this article, but were cultured the various LPSs and "N. sanguineum" [19] . Negative control was assayed without primary antibody.
within two hours of nephrectomy. Aliquots (0.5 mL) of nonfiltered and filtered (0.45 pore size; Millipore Corp., Dissected kidney tissue and pellets of cyst fluids (15,000 ϫ g, 45 min) were prepared for electron microsBedford, MA, USA) cyst fluid were placed in 5 mL of RPMI-1640 (Cellgro Mediatech Inc., Herndon, VA, copy by initial fixation in cold 2.5% glutaraldehyde and processing as previously described [37] . For nanobact-USA) with and without 10% H␥-FBS (Life Technoloeria, uranyl acetate staining was omitted without loss or gies, Grand Island, NY, USA) in T-25 flasks and incualteration of nanobacterial morphology. bated as previously in this article. After one month, the For culture of nanobacteria (donors 1 through 13), cultured cyst fluids were examined by phase light and frozen original cyst fluids or urines were thawed; 0.5 mL electron microscopy. Sterile controls were media with aliquots of the original and filtered (0.22 pore size and without H␥-irradiated serum. filter) were placed in 5 mL of RPMI-1640 with l-glutaAn initial determination of cytotoxic potential of namine (GIBCO, Paisley, Scotland, UK) supplemented nobacteria from PKD patients used a 3T6-fibroblast with 10% high ␥-irradiated (30 kGy), heat-inactivated (ATCC CCL 96) test system described elsewhere [26] . fetal bovine serum (H␥-FBS; Atlanta Biologicals, At-
The loss of fibroblasts caused by cell lysis was easily lanta, GA, USA) in T-25 tissue culture flasks and incuobserved by direct microscopic inspection. bated at 37ЊC in a humidified 5% CO 2 /95% air environNanobacterial growth in response to tetracycline and ment for three weeks [19] [20] [21] 26 ]. The identification of citrate solutions was assessed in 96-well plates by renanobacteria used phase contrast microscopy, IF assay cording the increase in optical density at 650 nm over a with Nb 8/0 as the primary antibody, differential DNA-14-day period [22, 25] . Serial dilutions of potassium cistaining using Hoechst 33258 fluorochrome (Flow Labotrate-citric acid solution described by Tanner were made ratories, Ayrshire, Scotland, UK) that distinguishes nain Dulbecco's modified Eagle's medium with 1 mmol/L nobacteria from common bacteria, and a double staining glutamine (DMEM; Sigma, St. Louis, MO, USA) [38] . method that combined both IF and Hoechst methods [19, 20, 23, 24, 26] . The results were recorded by light RESULTS and fluorescence photomicroscopy. TEM was also used Endotoxin or its remnants were found in all PKD to visualize nanobacteria in specimens with the type culkidneys examined in this study. Table 1 lists our findings ture designate serving as the control for growth and morphologic comparison.
of endotoxin by dLAL and dot-immunoblot method.
For each patient, the number of cyst fluids found to be these data do not exclude the possibility that chlamydial LPS is also present. The lack of strict stoichiometry positive by dLAL for endotoxin per the number of fluids tested (p/t) is given. For the dLAL assay, the average across microbial epitopes may reflect different rates of generation, release, and degradation within cyst fluid or level of detected endotoxin expressed in endotoxin units (EUs)/mL cyst fluid is given for those cysts positive for delivery of epitopes to cysts from other sites. By dot-immunoblot assay, 10 of 10 liver cyst fluids endotoxin. In patients 1 through 7, all of whom had been on dialysis or received a kidney transplant prior to nepositive for nanobacteria were also positive for Bartonella (donor 2; Table 1 ). In 31 kidney cyst fluids selected phrectomy, the average endotoxin load (0.245 EU/mL) was sevenfold lower than for patients 8 through 12 (1.70 from the ADPKD donors 1 through 12, a very similar but not identical distribution of antigens for these organ-EU/mL) who had not received renal replacement therapy. The incidence of dLAL positivity for cyst fluids isms was observed. Twenty-one fluids were positive for both Bartonella and nanobacteria (Nb 8/0 and 5/2). Seven within each kidney was also lower in the renal replacement group (20.2 vs. 43.7%, respectively).
were negative for both organisms. One was weakly positive only for nanobacteria (Nb 8/0 and 5/2), and two In ADPKD patients, there was a greater rate of positivity by dot-immunoblot for endotoxin than by dLAL were weakly positive only for Bartonella. Washed, intact nanobacteria were negative by dot-immunoblot assay to ( Table 1 ). The LPS antibodies recognized epitopes in the core polysaccharides of LPS and thus did not require hyperimmune serum to B. henselae (HS-Bh). However, incubation of nanobacteria at 37ЊC for one hour in 100 an intact lipid A moiety for reactivity. A difference in the rates of dLAL and dot immunoblot positivity sugmmol/L EGTA rendered the decalcified nanobacteria reactive with HS-Bh; no reaction was observed when gests the presence of LPS remnants, which was observed in all PKD kidneys examined in this study.
HS-Bh was omitted from the assay. Simple kidney cyst fluid from donor 13 also reacted with these antibodies "Nanobacterium sanguineum" was positive for endotoxin, but not glucan by the dLAL assay; pretreatment (Table 1) . HS-Bh did not react with ATCC reference strains of E. coli or B. fragilis. of "N. sanguineum" and nanobacteria from donor 14 with EGTA prior to dLAL assay enhanced endotoxin
In an earlier study, we found endotoxin in the urine of a majority of PKD patients, but only comparatively positivity eightfold. By TEM, PKD kidney tissue and cyst fluids exhibited mineralized structures compatible low levels in control females and none in control males [17] . Here, we assayed archived urine from the previous with nanobacteria ( Figs. 1 and 2) ; neither Chlamydia nor Bartonella-like structures nor other common microbes study by dot-immunoblot using Nb 8/0 and WN1 222.5 (Table 2) . Nb 8/0 gave the highest positivity in PKD were observed. Antibodies Nb 8/0 and Nb 5/2 against "Nanobacterium sanguineum" showed a high incidence males with normal males showing greater positivity than normal females. In one PKD male, four sequential urine of positivity in kidney cysts from all 13 ADPKD patients (Table 1) [19, 23] . Positivity was also observed in liver samples collected over a two year period exhibited Nb8/0 positivity (scores 3, 1, 2, 4), while three urines from each cyst fluids and simple kidney cyst fluid where available. As exemplified by Figure 1H , common bacteria were of two PKD females remained negative over this same period. The antibodies against E. coli LPS was reactive not present, as determined by Hoechst staining, in the nanobacteria cultures from PKD cyst fluids.
with all PKD male urines; 4 of 10 of the normal females were also WN1 222.5 positive. During checks of antibody specificity, chlamydial LPS mAb was observed to react with washed, intact nanoStructures consistent with nanobacteria were observed by TEM in PKD kidney tissue (Table 1 and Fig. 1 ). bacteria. This mAb did not cross-react with purified LPS from either E. coli (ATCC #25922) or B. fragilis (ATCC Nanobacteria were cultured from frozen kidney cyst fluids from donors 1, 2, 3, 5, 7 through 13 and identified #25215), reference organisms used by the National Committee for Clinical Laboratory Standards. "Nanobacterby IF methods (Table 1 and Fig. 1 ). They were also found by culture and IF in blood and urine samples from ium sanguineum" did not react with the other LPS antibodies. This raised the possibility that our positive a 23-year-old Finnish male PKD patient. Multiple kidney cyst fluids were cultured without prior freezing from findings of chlamydial LPS in cyst fluids could be due to the LPS of nanobacteria. donor 14 (Table 1) , who had received both hemodialysis for 10 months and a kidney transplant 4 months prior Of the 66 kidney and liver cyst fluids assayed using mAb to chlamydia LPS and nanobacterial porin and to nephrectomy. All 15 nonfiltered cyst fluids grown in serum for four weeks were nanobacteria positive by light peptidoglycan antigens (Nb 8/0 and Nb 5/2; Table 1), 39 were positive with all three mAbs, 18 positive for only microscopy. In selected cultures, TEM (Fig. 2 c, g ) and dot-immunoblot with Nb 8/0 confirmed the growth to Nb 8/0 and Nb 5/2, 7 negative for all three, and 2 positive only for chlamydial LPS. Thus, nearly all of the reactivity be nanobacteria. Growth media plus serum alone were negative by dot-blot, light, and electron microscopy ( to 500 nm) and calcification are two essential characteristics of nanobacteria morphology. These criteria make a compelling case for the presence of nanobacteria in PKD. The immunologic cross reactivity of nanobacteria positive when grown in serum-fortified media, and in with two other known pathogens (Chlamydia and Bartoserum-free media only 6 showed growth by light microsnella) requires the use of multiple criteria to establish copy. For nonfiltered cyst fluids cultured in serum-free identity. Sequencing of novel nanobacterial proteins for media, 10 of 15 were culture positive by light microscopy.
use as antigens may yield additional immunologic probes By TEM and light microscopy, nanobacteria isolates for nanobacteria in human specimens (Kajander, unpubfrom donor 14 were indistinguishable from "Nanobacterlished data). Poor penetration of the calcium coat by ium sanguineum" incubated in media with and without DNA probes may limit a DNA-based approach to cliniserum for four weeks (Fig. 2 b, f) .
cal specimens (Kajander, unpublished 
data). In two flasks of nonfiltered cyst fluid incubated in serum-
It is possible that humans are routinely exposed to free media, nanobacteria were observed to be bound to nanobacteria and clear them as a matter of normal physiand present within PKD renal epithelial cells that were ology. Five percent of 1000 Finnish volunteers exhibited present in the aspirated cyst fluid (Fig. 3) . By directnanobacteremia [23] . In this United States-based study, phase microscopy, nanobacteria were observed to be control males (30%) and females (10%) exhibited nanoactively endocytosed by the PKD cells in vitro (data bacterial antigen in their urine (Table 2 ). In an unpubnot shown). The epithelial cells exhibited intracellular lished work (Hjelle), 20 of 50 consecutive non-PKD hustructures typical of highly mineralized forms of nanoman kidney biopsies examined thoroughly by EM for bacteria (Fig. 3B ) and other pleomorphic forms of nanonanobacteria showed structures compatible with nanobacteria in vitro (Fig. 3C) [19, 20, 23] . Conditioned media bacteria. Only patients with compromised kidney funcfrom this cell-containing culture of cyst fluid were position (nondialyzed) were biopsied. As 60% of human kidtive for endotoxin by the dLAL assay; both the filtered ney biopsies did not show evidence of nanobacteria, they and unfiltered cyst fluids grew nanobacteria. might serve as a surrogate for control human kidney Using a 3T6-fibroblast test system, nanobacteria isotissue. At this time, it is not known whether these findings lates from donors 1, 7, 8, 12, and 13 were screened for represent episodic/continuous infections or colonizations. cytotoxicity. These isolates caused cytotoxicity that ranged Theoretically, disease would occur if (1) nanobacteria from mild to severe (20 to 100% cell loss compared to could not be cleared, (2) Regarding these three general points, (1) the kidney 1 F, G). When examined after 18 hours of incubation, may play an important role in the clearance for this tiny, sequestration of IF signal within the 3T6 cells was apparcalcium-coated cytotoxic organism. Akerman et al have ent (Fig. 1H) .
reported that radiolabeled, viable nanobacteria appeared The initial test of PKD-derived nanobacteria susceptiin urine within 15 minutes of their intravenous injection bility to an antimicrobial agent used a serum-derived nainto rabbits [27] . By TEM and silver staining, nanobactnobacteria isolate from a 23-year-old Finnish PKD patient eria were associated with the tubule epithelium and fluid. and tetracycline at 4 g/mL, which completely inhibited Nanobacteria were not observed in the control animals. growth (Fig. 4) . In the absence of inhibitors, absorbance Apoptosis of tubule cells at the site of nanobacterial increased, indicating growth of nanobacteria typical of localization was observed. Dysregulation of apoptosis a bacterial growth curve. Serial dilutions of potassium citrate-citric acid (55 mmol/L/67 mmol/L) in DMEM and tubular obstruction are frequently observed in PKD a variety of animal sources [26] . The five random nanobacterial isolates from separate cystic kidneys (4 PKD, 1 simple cystic disease) tested in this study exhibited cytotoxicity. The cytotoxic components of nanobacteria are yet to be identified, but candidate toxins include its putative chlamydia-like endotoxin reported here and its mineral coat, which may contribute to free-radical formation [39] . The LPS of Chlamydia pneumoniae is reported to be a key component in its atherogenic effect [40] . Endotoxin from at least two other genera of bacteria was identified in cyst fluid. Thus, a portion of the renal inflammation observed in PKD kidney [10] may be related to the presence of endotoxin, a potent inflammatory agent and nephrotoxin. Related and cross-reacting pathogens may share similar virulence factors and mechanisms of toxicity. Maurin et al reported serological cross reactions between Bartonella and Chlamydia species for LPS and non-LPS epitopes [41] . We found hyperimmune sera to B. henselae, a close phylogenetic relative of nanobacteria, reacted with "Nanobacterium sanguineum" and cyst fluids from all 12 PKD patients examined. Kajander et al observed that Nb 5/2, but not Nb 8/0, reacted with intact Bartonella [19] . Interestingly, patients with bacillary peliosis caused by B. henselae develop cystic liver lesions [42] . Bartonella sp. are also linked to cardiac and vascular lesions [43] . In PKD, cardiac and vascular lesions are a leading cause of death, and liver cysts are found in 77% of patients by age 60 [6] . The expression of Bartonella-induced pathology is influenced by the patient's immunocompetency [43] , a concept of potential relevance to PKD patients and their reported heightened vulnerability to infection [14] . tions). C. pneumoniae has recently been implicated by immunologic methods in the calcifying cardiovascular disease observed in patients with renal failure [44] , but pathophysiology [28, 29, 31 ]. An inability to clear ob-C. pneumoniae has not been reported to cause tissue structed tubules would lead to retention of nanobacteria, calcification. Carson has proposed that all extraskeletal thereby providing selection pressure for the emergence calcifications are caused by nanobacteria, the only known of more progressively cystic phenotypes [7, 8, 10, 11] .
blood-born, calcium apatite-forming microbe [45] . Accumulation of nanobacteria caused by the lack of re-(3) Four points (a through d) relate to genetic/environnal clearance would be consistent with their presence mental factors that impact PKD. (a) The distribution of within poorly drained PKD cysts and simple kidney cysts PKD lesions in kidney, liver, vasculature, spleen, heart, and the 80% rate of nanobacteremia in hemodialysis and colon follows the expression of polycystin 1, one of patients [23] . Interestingly, 80% of non-PKD dialysis two proteins regarded as defective in PKD [11] and that patients will develop acquired kidney cysts [6] .
we have speculated may bind microbes or their compo-(2) Pathogenic and nonpathogenic strains of nanobactnents [9] . In this study, we found nanobacteria and/or eria are possible given the range of cytotoxicities (no its antigens consistently in PKD kidneys, the available multiple liver cysts from one patient and blood and urine toxicity to 100% cell death) produced by isolates from of another. While it is unknown whether nanobacteria currence and severity of kidney cysts, which are greater in males, and liver cysts, which are greater in females [2, 6] . bind to normal or PKD-defective polycystins, nanobacteria of PKD origin were found bound to and present These consistent, but as yet unexplained gender differences in expression of PKD pathology and pharmacology in human PKD kidney cells in vivo and in vitro (Figs. 1  and 3 ) and rodent fibroblasts in vitro (Fig. 2) . Cytotoxic- [49] are now reflected in the occurrence of nanobacterial antigens in PKD urines (Table 2 : PKD males Ͼ control ity was evident. Endocytosis of nanobacteria or its remnants was required to induce apoptosis in fibroblasts [26] , males Ͼ PKD females Ϸ control females). In contrast, the endotoxin levels found in PKD individuals were greater a cell type that expresses polycystin 1 [11] . Calvet has proposed that PKD involves a defect in cellular repair than those found in control females. Findings of both E. coli LPS antigen and fivefold lower levels of Limulus mechanisms that would make PKD individuals especially vulnerable to commonly encountered renotoxic environAmoebocyte Lysate positivity in control females may be due simply to introital contamination (Table 2 ) [17] . mental factors [11, 46] .
(b) Kidney calcifications become several-fold more In summary, we demonstrate that cytotoxic nanobacteria are present in PKD patients. Based on our data, prevalent in PKD individuals than in the general population [30] . Nanobacteria are now strongly linked to kidney we propose that the currently known cellular toxicities, tissue distribution, and pharmacology of nanobacteria stone formation [24] . Hypocitraturia is a risk factor for kidney stones [47] . The relationship between kidney calciare plausibly related to the known pathology and pharmacology of PKD. The mechanism responsible for the fication and cystogenesis is unclear. However, exogenous citrate prevented loss of kidney function in genetically heightened vulnerability of PKD individuals to infection and the lesions of PKD is unknown, but must ultimately PKD rats [38] . Dietary flaxseed meal, which increased citrate levels in the kidney, also preserved kidney funcinvolve the loss of functional polycystins [10, 11] . Awareness that nanobacteria are present in PKD, and likely tion in genetically PKD rats [48] . Based on our observation that citrate inhibits nanobacterial growth in vitro other kidney diseases and hemodialysis, may lead to improved therapies and management. Additional re- (Fig. 4B) , we propose that citrate protects against nanobacteria-driven stone formation in general and loss of search is required to prove that nanobacteria promote PKD. Such infectious disease research will need careful kidney function and reduced cyst volumes in PKD.
The mineral coat of nanobacteria may play a role in attention to the resistance of nanobacteria to most disinthe concentration, persistence, and resultant killing action fectants and routine sterilizing techniques (that is, autoof tetracycline, a drug known to bind calcium and used in claving, radiation, filtration) [19, 22, 23] , and the presence the treatment of diseases with pathological calcifications.
of nanobacteria in serum used for tissue culture [19, 20] . Putative C. pneumoniae infections have been treated with tetracycline, a drug that also inhibited the growth in vitro NOTE ADDED IN PROOF of PKD and animal isolates of nanobacteria (Fig. 4A) .
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(d) Gender differences have been reported for the oc-
